Previous Section
Clinical Trials
101. Phase II study of 3-week scheduling of irinotecan in combination with cisplatin in patients with advanced nonsmall-cell lung cancer.
- Author
- Saito H; Kudoh S; Nakagawa K; Negoro S; Matsui K; Semba H; Takada M;
- Institution
- Department of Respiratory Medicine, Aichi Cancer Center Aichi Hospital, Okazaki, Japan. hsaito@sun-inet.or.jp
- Journal
- Am J Clin Oncol. 2006 Oct;29(5):503-7.
- Abstract URL
- Click here to view abstract
102. Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.
- Author
- Lilenbaum R; Socinski MA; Altorki NK; Hart LL; Keresztes RS; Hariharan S; Morrison ME; Fayyad R; Bonomi P;
- Institution
- Mount Sinai Cancer Center, Miami Beach, FL 33140, USA. rlilenbaum@aptiumoncology.com
- Journal
- J Clin Oncol. 2006 Oct 20;24(30):4825-32.
- Abstract URL
- Click here to view abstract
103. Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies.
- Author
- Govindan R; Crowley J; Schwartzberg L; Kennedy P; Williams C; Ekstrand B; Sandler A; Jaunakais D; Bolejack V; Ghalie R;
- Institution
- Washington University School of Medicine, St Louis, MO 63110, USA. rgovinda@im.wustl.edu
- Journal
- J Clin Oncol. 2006 Oct 20;24(30):4848-54.
- Abstract URL
- Click here to view abstract
104. Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.
- Author
- Giaccone G; Gallegos Ruiz M; Le Chevalier T; Thatcher N; Smit E; Rodriguez JA; Janne P; Oulid-Aissa D; Soria JC;
- Institution
- Department of Medical Oncology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands. g.giaccone@vumc.nl
- Journal
- Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6049-55.
- Abstract URL
- Click here to view abstract
105. Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
- Author
- Fanucchi MP; Fossella FV; Belt R; Natale R; Fidias P; Carbone DP; Govindan R; Raez LE; Robert F; Ribeiro M; Akerley W; Kelly K; Limentani SA; Crawford J; Reimers HJ; Axelrod R; Kashala O; Sheng S; Schiller JH;
- Institution
- Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
- Journal
- J Clin Oncol. 2006 Nov 1;24(31):5025-33.
- Abstract URL
- Click here to view abstract
106. A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.
- Author
- Ross HJ; Hart LL; Swanson PM; Rarick MU; Figlin RA; Jacobs AD; McCune DE; Rosenberg AH; Baron AD; Grove LE; Thorn MD; Miller DM; Drachman JG; Rudin CM;
- Institution
- Thoracic Oncology Program, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, 4805 NE Glisan Street, #5F40 Portland, OR 97213, United States. hross@orclinic.com
- Journal
- Lung Cancer. 2006 Oct;54(1):69-77. Epub 2006 Aug 28.
- Abstract URL
- Click here to view abstract
107. Phase II study of combination chemotherapy with gemcitabine and irinotecan in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.
- Author
- Ohyanagi F; Taguchi F; Horai T; Kasahara K; Takeda Y; Shibata K; Shirosaki H; Nishio M;
- Institution
- Thoracic Oncology Center, Cancer Institute Hospital, Koto-ku, Tokyo 135-8550, Japan.
- Journal
- Jpn J Clin Oncol. 2006 Sep;36(9):547-51. Epub 2006 Jul 26.
- Abstract URL
- Click here to view abstract
108. Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status.
- Author
- Norsa A; Martino V;
- Institution
- Thoracic Surgery Unit, Ospedale Maggiore Azienda Ospedaliera, Verona, Italy. norsaachille@yahoo.it
- Journal
- Cancer Biother Radiopharm. 2006 Feb;21(1):68-73.
- Abstract URL
- Click here to view abstract
109. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
- Author
- Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
- Institution
- University of California, Davis, Sacramento, CA, USA. angela.davies@ucdmc.ucdavis.edu
- Journal
- J Clin Oncol. 2006 Nov 20;24(33):5242-6.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
